TCM
VERA icon

Tang Capital Management’s Vera Therapeutics VERA Stock Holding History

Tang Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,350,000
Closed -$39.2M – 183
2025
Q3 		$39.2M Hold
1,350,000
– – 1.51% 18
2025
Q2 		$31.8M Buy
1,350,000
+1,200,000
+800% +$27M 1.61% 15
2025
Q1 		$3.6M Buy
+150,000
New +$4.82M 0.2% 88

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Tang Capital Management's VERA Position: Q4 2025 in Review

Tang Capital Management sold out of Vera Therapeutics (VERA) in Q4 2025, closing a stake of 1,350,000 shares — an estimated $39.2M sold.

Tang Capital Management first reported a position in VERA in Q1 2025 and held it in 3 quarters. The position peaked at $39.2M in Q3 2025. 214 funds tracked by Wall St. Rank hold VERA as of Q4 2025.

  • Tang Capital Management reported no remaining Vera Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 1,350,000 Vera Therapeutics shares in Q4 2025, an estimated $39.2M.
  • Tang Capital Management first reported a position in Vera Therapeutics in Q1 2025 and held it in 3 quarters.
  • Tang Capital Management's Vera Therapeutics position peaked at $39.2M in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.